Robert P. Driscoll
Nessuna posizione attualmente
Profilo
Prior to joining BioAdvance Mr. Driscoll was controller with BioRexis Pharmaceutical Corporation (acquired by Pfizer Corporation).
He also served as controller with Targeted Genetics Corporation (formerly Genovo, Inc.), and he held financial management positions with Nexell Therapeutics, Kulicke & Soffa Industries, Pfizer and ICI Americas.
Mr. Driscoll holds a Masters of Science in financial management and a Bachelor of Science in accounting from Drexel University.
Precedenti posizioni note di Robert P. Driscoll
| Società | Posizione | Fine |
|---|---|---|
BioRexis Pharmaceutical Corp.
 BioRexis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology BioRexis Pharmaceutical Corp. provides novel protein and peptide drugs with pharmacology and trans-bodies to replace conventional monoclonal antibodies. The company was founded by Christopher P. Prior, Andrew Turner and David R. King in 2002 and is headquartered in Rosemont, PA. | Corporate Officer/Principal | - |
Formazione di Robert P. Driscoll
| Drexel University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
BioRexis Pharmaceutical Corp.
BioRexis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology BioRexis Pharmaceutical Corp. provides novel protein and peptide drugs with pharmacology and trans-bodies to replace conventional monoclonal antibodies. The company was founded by Christopher P. Prior, Andrew Turner and David R. King in 2002 and is headquartered in Rosemont, PA. | Health Technology |
- Borsa valori
- Insiders
- Robert P. Driscoll
